Compare ALEMBIC PHARMA with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs TORRENT PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA TORRENT PHARMA ALEMBIC PHARMA/
TORRENT PHARMA
 
P/E (TTM) x 27.7 62.6 44.2% View Chart
P/BV x 2.8 8.3 33.4% View Chart
Dividend Yield % 1.9 1.2 158.4%  

Financials

 ALEMBIC PHARMA   TORRENT PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-21
TORRENT PHARMA
Mar-21
ALEMBIC PHARMA/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1,1503,040 37.8%   
Low Rs5271,933 27.3%   
Sales per share (Unadj.) Rs274.4473.0 58.0%  
Earnings per share (Unadj.) Rs56.774.0 76.7%  
Cash flow per share (Unadj.) Rs66.0112.9 58.5%  
Dividends per share (Unadj.) Rs14.0035.00 40.0%  
Avg Dividend yield %1.71.4 118.6%  
Book value per share (Unadj.) Rs260.9344.9 75.6%  
Shares outstanding (eoy) m196.56169.22 116.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.15.3 58.1%   
Avg P/E ratio x14.833.6 44.0%  
P/CF ratio (eoy) x12.722.0 57.6%  
Price / Book Value ratio x3.27.2 44.6%  
Dividend payout %24.747.3 52.2%   
Avg Mkt Cap Rs m164,818420,798 39.2%   
No. of employees `000NANA-   
Total wages/salary Rs m10,51214,396 73.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,93180,048 67.4%  
Other income Rs m875757 115.5%   
Total revenues Rs m54,80680,806 67.8%   
Gross profit Rs m14,80124,666 60.0%  
Depreciation Rs m1,8356,578 27.9%   
Interest Rs m1603,583 4.5%   
Profit before tax Rs m13,68115,263 89.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,5332,744 92.3%   
Profit after tax Rs m11,14812,519 89.0%  
Gross profit margin %27.430.8 89.1%  
Effective tax rate %18.518.0 103.0%   
Net profit margin %20.715.6 132.2%  
BALANCE SHEET DATA
Current assets Rs m25,77955,232 46.7%   
Current liabilities Rs m12,80848,916 26.2%   
Net working cap to sales %24.17.9 304.8%  
Current ratio x2.01.1 178.3%  
Inventory Days Days2314 163.6%  
Debtors Days Days27 34.0%  
Net fixed assets Rs m41,31181,298 50.8%   
Share capital Rs m393846 46.5%   
"Free" reserves Rs m50,88357,526 88.5%   
Net worth Rs m51,27658,372 87.8%   
Long term debt Rs m1,99929,633 6.7%   
Total assets Rs m67,090136,530 49.1%  
Interest coverage x86.45.3 1,642.6%   
Debt to equity ratio x00.5 7.7%  
Sales to assets ratio x0.80.6 137.1%   
Return on assets %16.911.8 142.9%  
Return on equity %21.721.4 101.4%  
Return on capital %26.021.4 121.3%  
Exports to sales %66.80-   
Imports to sales %12.70-   
Exports (fob) Rs m36,020NA-   
Imports (cif) Rs m6,845NA-   
Fx inflow Rs m36,02021,539 167.2%   
Fx outflow Rs m6,8457,136 95.9%   
Net fx Rs m29,17514,403 202.6%   
CASH FLOW
From Operations Rs m14,63420,107 72.8%  
From Investments Rs m-8,388-4,494 186.6%  
From Financial Activity Rs m-5,974-16,561 36.1%  
Net Cashflow Rs m262-893 -29.4%  

Share Holding

Indian Promoters % 69.1 71.3 97.0%  
Foreign collaborators % 0.5 0.0 -  
Indian inst/Mut Fund % 17.8 20.6 86.1%  
FIIs % 6.0 10.9 55.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 28.8 105.7%  
Shareholders   106,437 63,229 168.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   SUN PHARMA    CIPLA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    

Yellow Ad

Advertisement

A One Stock Gift in 1990 Turns into Rs 130 Crores

In 2017, Ravi made headlines by calling a leading business news channel with a surprising announcement - his grandfather had left him 20,000 shares of only one stock.

And on the day of his call - these shares were worth Rs 130 crore.

Can you guess which is this company?

It's MRF.

Ravi's story is one of the amazing stories of becoming Crorepati from a single stock.

But the question is, how to find that one stock with crorepati potential?

To find the answer to this million-dollar question, join our 'One Stock Crorepati' MEGA summit on 30th June, where we will reveal details of what we call a potential 'crorepati' stock...

Learn more



Today's Market

Sensex Zooms 462 Points, Nifty Ends Near 15,700; Auto & FMCG Stocks Rally(Closing)

Indian share markets ended the week on a firm note tracking positive global cues.

Related Views on News

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks(Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Why Tata Power Share Price is Falling(Views On News)

Jun 14, 2022

Here's why shares of Tata Power have fallen in recent days.

Is it Time to Start Buying Stocks Selectively?(Profit Hunter)

Jun 16, 2022

Some sectors have corrected by 50%. Do they merit a look?

Best Monopoly Stocks to Own in 2022(Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

When Will the Stock Market Recover?(Views On News)

Jun 15, 2022

This is how you can tell the market is going to recover.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jun 24, 2022 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS